Cigna; Express Scripts Announce Program to Cap Insulin Cost to $25/Month

Cigna and Express Scripts announced today the launch of a new program which will ensure eligible people with diabetes in participating plans pay no …

Janssen Submits sNDA for INVOKANA® for Chronic Kidney Disease in Patients with Type 2 Diabetes

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the …

Oramed Gets Patent for Key Aspect of Its Oral Delivery Technology in U.S.

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has …

Chinese Regulatory Authority Approves IND Application of Oramed’s Oral Insulin Capsules

Oramed Pharmaceuticals Inc., a company developing of oral drug delivery systems, announced today that its Chinese partner, Hefei Tianhui Incubator …

Study Explaining Side Effects of Statins Finds Drug Can Have Unexpected Benefits

While investigating why cholesterol-lowering drugs called statins cause negative side effects such as blurred vision, short-term memory loss or …

New “Pill” That Can Deliver Insulin Could Replace Injections for Patients with Type 2 Diabetes

An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that …

FDA Approves Use of 0.5 mL Dose of Influenza Vaccine in Children as Young as 6 Months of Age

The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone® Quadrivalent (influenza vaccine) to include children …

Genetics of Human Fat Cells Used to Predict Response to Anti-Diabetes Drugs

A new study from Penn Medicine shows that a person’s individual genetic variation may affect which medications are best to take. Drugs called …

Sky-rocketing Insulin Prices Prompt New Movement Across the U.S.

More than 7 million Americans are insulin dependent. And recent findings show that 1-in-4 Americans are rationing their insulin, a dangerous way …

One in Four Patients Skimp on Insulin Because of High Cost, Study

One-quarter of patients with type 1 or type 2 diabetes have reported using less insulin than prescribed due to high costs, a new Yale University …